SOPHiA GENETICS Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	62.37	47.56	40.45	28.4	25.36
Revenue Growth (YoY)	31.14%	17.58%	42.43%	11.98%	-
Cost of Revenue	19.46	16.31	15.23	10.71	7.53
Gross Profit	42.91	31.25	25.22	17.69	17.83
Selling, General & Admin	81.72	84.08	70.24	36.4	35.08
Research & Development	36.97	35.37	26.58	18.59	15.02
Other Operating Expenses	-0.95	-0.38	-0.11	0.09	0.02
Operating Expenses	117.74	119.08	96.71	55.08	50.12
Operating Income	-74.83	-87.82	-71.49	-37.39	-32.29
Interest Expense / Income	-3.96	-0.69	0.64	3.84	1.34
Other Expense / Income	7.63	0.45	1.38	-	-
Pretax Income	-78.5	-87.59	-73.51	-41.23	-33.63
Income Tax	0.49	-0.14	0.17	-1.89	0.16
Net Income	-78.98	-87.45	-73.68	-39.34	-33.79
Shares Outstanding (Basic)	65	64	64	63	-
Shares Change	1.43%	0.55%	0.82%	-	-
EPS (Basic)	-1.22	-1.36	-1.33	-0.93	-0.90
EPS (Diluted)	-1.22	-1.36	-1.33	-0.93	-0.90
Free Cash Flow	-50.07	-74.19	-60.62	-32.18	-33.04
Free Cash Flow Per Share	-0.77	-1.16	-0.95	-0.51	-
Gross Margin	68.80%	65.71%	62.35%	62.29%	70.30%
Operating Margin	-119.97%	-184.66%	-176.73%	-131.64%	-127.30%
Profit Margin	-126.63%	-183.87%	-182.14%	-138.52%	-133.23%
Free Cash Flow Margin	-80.28%	-155.99%	-149.87%	-113.31%	-130.25%
EBITDA	-74.12	-82.7	-69.26	-35	-30.37
EBITDA Margin	-118.83%	-173.88%	-171.22%	-123.23%	-119.76%
Depreciation & Amortization	8.34	5.57	3.61	2.39	1.91
EBIT	-82.45	-88.27	-72.87	-37.39	-32.29
EBIT Margin	-132.20%	-185.60%	-180.15%	-131.64%	-127.30%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).